ELAVL1 degrader molecular glue therapy(Degron therapeutics)

N/A

Report date: 2025/01/14 09:28:01
NME

Base Information

Drug NameELAVL1 degrader molecular glue therapy(Degron therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionELAV-like protein 1 inhibitors
TargetsELAV-like protein 1
Therapy Area/IndicationsLarge intestine neoplasmCarcinoma, HepatocellularGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Dage Biomedical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Dage Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsLarge intestine neoplasmCarcinoma, HepatocellularGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A